Cargando…
Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study
OBJECTIVES: To examine the association between use of second-generation antipsychotics (SGA) and the risk of chronic kidney disease (CKD). DESIGN: Population-based case-control study. SETTING: Routinely collected laboratory, prescription and diagnostic information on all inhabitants with creatinine...
Autores principales: | Højlund, Mikkel, Lund, Lars Christian, Herping, Jonas Leander Emming, Haastrup, Maija Bruun, Damkier, Per, Henriksen, Daniel Pilsgaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418669/ https://www.ncbi.nlm.nih.gov/pubmed/32784262 http://dx.doi.org/10.1136/bmjopen-2020-038247 |
Ejemplares similares
-
Lithium and the risk of chronic kidney disease: A population‐based case–control study
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study
por: Wang, Hsien-Yi, et al.
Publicado: (2018) -
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions
por: Kristensen, Kasper Bruun, et al.
Publicado: (2022) -
Insulin allergy can be successfully managed by a systematic approach
por: Haastrup, Maija Bruun, et al.
Publicado: (2018) -
Statin use before and after the KDIGO Lipids in chronic kidney disease guideline: A population‐based interrupted time series analysis
por: Kampmann, Jan D., et al.
Publicado: (2022)